CTO and Co-Founder

Numerate

Brandon Allgood is the CTO and cofounder at Numerate, Inc, an AI driven drug discovery company.

Brandon leads research and development of Numerate’s AI platform. He also leads the data science group, is the primary technical lead on both internal and collaborative drug discovery programs and is responsible for the technology vision at Numerate.

Brandon has previously served as Director of Computational Science at Numerate and as a Research Scientist at Pharmix. He received a B.S. in Physics from the University of Washington, Seattle, and a Ph.D. in Computational Physics from the University of California, Santa Cruz.

Brandon has authored scientific publications in astrophysics, solid-state physics, and computational chemistry and biology and has 15 years of experience in AI, mathematical modeling, and large scale cloud and distributed computing. He advises a number of venture capital firms and start-up companies, is a founder of the Alliance for AI in Healthcare, a member of the Forbes Technology Council and a UCSC Foundation Trustee.

Latest insights

Fri Mar 13 2020

Did an experimental drug help a U.S. coronavirus patient?

Fri Jan 10 2020

MoneyBall Medicine: Tom Davenport on the Analytics Gap in Healthcare

Wed Dec 18 2019

MoneyBall Medicine – Milind Kamkolkar on Seeing the Forest and the Tr...

Fri Nov 8 2019

Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery

Never miss an announcement